Brief: Kane Biotech Announces Fourth Quarter And Full Year 2022 Financial Results
20/04/2023 21:41
April 20 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS
* KANE BIOTECH INC - CASH AT DECEMBER 31, 2022 WAS $1.1
MILLION
COMPARED TO $1.15 MILLION AS OF DECEMBER 31, 2021
* KANE BIOTECH INC - QTRLY LOSS PER SHARE $0.01
Source text for Eikon: ID:nGNXR39J5
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update